CAT inhibition has been associated with risk of many different cancers, while its overexpression (e.g., in MCF-7 mammary cancer cells) has been reported to result in a less aggressive phenotype cancer cells and an altered response to chemotherapy [93,165]. Here, CAT is linked to breast cancer.